BDSI News Alert Biodelivery Sciences International (BDSI) 12.65

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biodelivery Sciences International (BDSI) 12.65 $BDSI

Endo/BioDelivery File Regulatory Application for Pain Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 3:45PM CST
Endo International along with its partner BioDelivery Sciences International, Inc. announced the submission of a new drug application for buprenorphine HCl buccal film.
BDSI: 12.65 (+0.66), ENDP: 72.10 (+0.34), AUXL: 34.40 (+0.18), AMGN: 160.67 (+3.15)

12.9% Return Seen to Date on SmarTrend BioDelivery Sciences Call (BDSI)
Comtex SmarTrend(R) - Wed Dec 24, 9:31AM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 1 month, BioDelivery Sciences has returned 12.95% as of today's recent price of $12.66.
BDSI: 12.65 (+0.66)

Strong On High Volume: BioDelivery Sciences International (BDSI)
at The Street - Wed Dec 24, 9:01AM CST
Trade-Ideas LLC identified BioDelivery Sciences International (BDSI) as a strong on high relative volume candidate
BDSI: 12.65 (+0.66)

Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain
PR Newswire Europe - Tue Dec 23, 3:15PM CST
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc , and BioDelivery Sciences International, Inc. announced today that they have submitted a New Drug Application (NDA) for Buprenorphine HCl Buccal Film to the U.S. Food and Drug Administration (FDA). Buprenorphine HCl Buccal Film is under development for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
BDSI: 12.65 (+0.66), ENDP: 72.10 (+0.34), ENL.TO: 83.00 (+0.91)

BioDelivery Sciences International (BDSI) Marked As A Dead Cat Bounce Stock
at The Street - Fri Dec 19, 8:45AM CST
Trade-Ideas LLC identified BioDelivery Sciences International (BDSI) as a "dead cat bounce" (down big yesterday but up big today) candidate
BDSI: 12.65 (+0.66)

Cancer Pain - Pipeline Review, H1 2014
M2 - Thu Dec 18, 4:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/xthht4/cancer_pain) has announced the addition of the "Cancer Pain - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Cancer Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cancer Pain and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Cancer Pain - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Cancer Pain pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Amgen - AstraZeneca - BioDelivery Sciences International - Nektar Therapeutics - Daiichi Sankyo Company - Egalet Corporation - Aphios Corporation - AcelRx Pharmaceuticals - Nippon Kayaku - Nippon Shinyaku - Orion - Pfizer - Zeria Pharmaceutical - GW Pharmaceuticals - IntelGenx - Benitec Biopharma - Kolon Life Science - Teikoku Seiyaku - BioAlliance Pharma - tesa Labtec - Colby Pharmaceutical - Grunenthal - AngioChem - WEX Pharmaceuticals - Virobay - QRxPharma - Winston Pharmaceuticals - Encore Therapeutics - Afferent Pharmaceuticals - Relevare Pharmaceuticals - Northern Light Pharmaceutical For more information visit http://www.researchandmarkets.com/research/xt...ancer_pain
BDSI: 12.65 (+0.66), ACRX: 6.61 (+0.06), EGLT: 5.97 (+0.21), AMGN: 160.67 (+3.15), NKTR: 15.02 (+0.23)

Insider Trading Alert - BDSI, LDRH And LNKD Traded By Insiders
at The Street - Wed Dec 17, 10:42AM CST
Stocks with insider trader activity include BDSI, LDRH and LNKD
BDSI: 12.65 (+0.66), LDRH: 33.82 (-0.26), LNKD: 231.83 (+0.34)

BioDelivery Sciences Down 13.0% Since SmarTrend Downtrend Call (BDSI)
Comtex SmarTrend(R) - Tue Dec 16, 5:25PM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 4 weeks, BioDelivery Sciences has returned 13.03% as of today's recent price of $12.65.
BDSI: 12.65 (+0.66)

BioDelivery Sciences International (BDSI) Strong On High Relative Volume Today
at The Street - Tue Dec 16, 9:02AM CST
Trade-Ideas LLC identified BioDelivery Sciences International (BDSI) as a strong on high relative volume candidate
BDSI: 12.65 (+0.66)

BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 8:02AM CST
BioDelivery Sciences has been witnessing a downward trend in its current year loss estimates and its share price has been falling for past few days
BDSI: 12.65 (+0.66), BIIB: 340.89 (+5.13), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)

Insider Trading Alert - HPJ, BDSI And MOH Traded By Insiders
at The Street - Mon Dec 15, 1:54PM CST
Stocks with insider trader activity include HPJ, BDSI and MOH
BDSI: 12.65 (+0.66), HPJ: 5.03 (+0.14), MOH: 53.39 (+0.61)

BioDelivery Sciences still rolling over
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:27AM CST

BDSI: 12.65 (+0.66)

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence
PR Newswire - Wed Dec 10, 7:00AM CST
BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI), who recently launched BUNAVAIL® (buprenorphine and naloxone) buccal film (CIII) for the maintenance treatment of opioid dependence, introduces InReach(TM), a novel support program for those affected by opioid dependence. The program consists of a website (accessible at www.inreachassist.com) and a mobile app (initially available for the iPhone here) that offer a comprehensive array of information and resources to support patients and their families.
BDSI: 12.65 (+0.66)

BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy
PR Newswire - Mon Dec 08, 6:00AM CST
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed the randomization of all patients in BDSI's ongoing initial pivotal Phase 3 clinical trial for Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN). BDSI anticipates that topline results of the study will be available by the end of March 2015.
BDSI: 12.65 (+0.66)

What Makes BioDelivery Sciences (BDSI) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 7:38AM CST
BioDelivery Sciences has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past 1 month
BDSI: 12.65 (+0.66), ANIP: 55.24 (+1.79), AMAG: 43.02 (+0.90), AFFX: 9.80 (+0.05)

BioDelivery Sciences to Present at the 26th Annual Piper Jaffray Healthcare Conference
PR Newswire - Tue Nov 25, 6:00AM CST
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26th Annual Piper Jaffray Healthcare Conference. The presentation is scheduled for Wednesday, December 3, 2014 at 10:30 a.m. Eastern Time at the New York Palace Hotel.
BDSI: 12.65 (+0.66)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago BioDelivery Sciences Is Down 12.3% (BDSI)
Comtex SmarTrend(R) - Mon Nov 24, 9:00AM CST
When BioDelivery Sciences (NASDAQ:BDSI) reported earnings 19 days ago on November 5th, 2014, analysts, on average, expected the company to report a loss of $0.24 on sales of $5.5 million. The company actually reported a loss of $0.51 per share on sales of $1.8 million, missing EPS estimates by $0.27 and missing revenue estimates by $3.7 million. Since the company's report, shares of BioDelivery Sciences have fallen from $16.30 to $14.29, representing a loss of 12.3% in the past 19 days.
BDSI: 12.65 (+0.66)

Earnings Look Back: BioDelivery Sciences Is Down 11.2% Since Reporting Quarterly Results 1 Week Ago (BDSI)
Comtex SmarTrend(R) - Mon Nov 17, 1:12PM CST
12 days ago, on November 5th, 2014, BioDelivery Sciences (NASDAQ:BDSI) reported its earnings. Analysts, on average, expected a loss of $0.24 per share on sales of $5.5 million. The company actually reported a loss of $0.51 per share on sales of $1.8 million, missing EPS estimates by $0.27 and missing revenue estimates by $3.7 million. Shares of BioDelivery Sciences have slipped from $16.30 to $14.47, representing a loss of 11.2%, since the company reported earnings 12 days ago.
BDSI: 12.65 (+0.66)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 118

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 100

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 44

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 66

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 71

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 89

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 87

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 50

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Luxury of the Mercedes-Benz EQS: Test Drive Today

Updated Category News Views 200

Experience the Mercedes-Benz EQS Test Drive at Arrowhead Drivers have a wonderful opportunity to immerse themselves in the world of electric luxury with the EQS at Mercedes-Benz of Arrowhead. This dealership is dedicated to providing an exceptional test drive experience, allowing potential buyers to see why this vehicle stands out in its class. With the surge in interest...

Continue Reading
Upcoming Financial Results and Conference Call for PROREIT

Updated Category News Views 103

Important Announcement from PROREIT PRO Real Estate Investment Trust, commonly known as PROREIT, is gearing up to share its financial performance for the 2024 fiscal year as well as the results for the fourth quarter. Scheduled for post-market release, this wave of data promises valuable insights for investors and stakeholders alike. The release will take place on an...

Continue Reading
Hearthside Food Solutions Seeks Bankruptcy Protection Amid Debt Issues

Updated Category News Views 293

Hearthside Food Solutions Files for Bankruptcy Hearthside Food Solutions has taken a significant step by filing for bankruptcy protection amidst deep financial strains. This decision comes as the company aims to reduce its staggering $1.9 billion debt and undertake a much-needed restructuring of its operations. The move follows troubling investigations into allegations of...

Continue Reading
New Affordable Housing Community Launched in San Antonio

Updated Category News Views 149

New Affordable Housing Community Opens in San Antonio The NRP Group, a leading developer known for its quality multifamily housing, has partnered with the City of San Antonio to celebrate the opening of a new affordable housing community called Los Arcos at Vida. This significant development, featuring 324 rental units, represents a crucial step forward in the ongoing...

Continue Reading
Insights on Dollar Tree's Stock Activity and Market Trends

Updated Category News Views 131

Understanding Dollar Tree's Investment Climate In the recent environment of stock trading, Dollar Tree (NASDAQ: DLTR) has caught the attention of many investors. A noticeable trend has emerged among deep-pocketed investors adopting a bearish stance towards the company. This change in sentiment is worth noting for those keeping tabs on the market. Market Activity Insights...

Continue Reading